- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Iambic Therapeutics Inc. (IAM)
Iambic Therapeutics Inc. stock price live, this page displays NASDAQ IAM stock exchange data. View the IAM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Iambic Therapeutics Inc. real time stock price chart below.
What Is the Iambic Therapeutics Inc. Stock Price Today?
The Iambic Therapeutics Inc. stock price today is 24,77.
What Is the Stock Symbol for Iambic Therapeutics Inc.?
The stock symbol for Iambic Therapeutics Inc. is "IAM."
What Stock Exchange Does Iambic Therapeutics Inc. Trade On?
Iambic Therapeutics Inc. is listed and trades on the NASDAQ stock exchange.
Is Iambic Therapeutics Inc. a Good Stock to Buy?
Determining whether Iambic Therapeutics Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IAM quote. (ISIN: US45076A1016)
What Is the Iambic Therapeutics Inc. Stock Price Today?
The Iambic Therapeutics Inc. stock price today is 24,77.
What Is the Stock Symbol for Iambic Therapeutics Inc.?
The stock symbol for Iambic Therapeutics Inc. is "IAM."
What Stock Exchange Does Iambic Therapeutics Inc. Trade On?
Iambic Therapeutics Inc. is listed and trades on the NASDAQ stock exchange.
Is Iambic Therapeutics Inc. a Good Stock to Buy?
Determining whether Iambic Therapeutics Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IAM quote. (ISIN: US45076A1016)
NASDAQ
Currency in USD
24.77
+5.86(+30.99%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.31
24.87
52 wk Range
16.15
24.87
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.3124.87
52 wk Range
16.1524.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IAM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Iambic Therapeutics prices IPO at $16 per share- Investing.com
- Iambic Therapeutics prices IPO at $16 per share
- Investing.com
Earnings
Latest Release
Sep 21, 2026
EPS / Forecast
-2,24 / --
Revenue / Forecast
12,75M / --
Compare IAM to Peers and Sector
Metrics to compare | IAM | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipIAMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.5x | −2.4x | −0.3x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | −3.9x | 1.1x | 2.6x | |
Price / LTM Sales | 49.1x | 58.4x | 2.9x | |
Upside (Analyst Target) | - | 261.9% | 64.3% | |
Fair Value Upside | Unlock | 8.8% | 9.9% | Unlock |
Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc. was formerly known as Entos, Inc. and changed its name to Iambic Therapeutics, Inc. in May 2023. The company was incorporated in 2019 and is based in San Diego, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Iambic Therapeutics (IAM) Stock Price Today?
The Iambic Therapeutics stock price today is 24,77 USD.
What Stock Exchange Does Iambic Therapeutics Trade On?
Iambic Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Iambic Therapeutics?
The stock symbol for Iambic Therapeutics is "IAM."
What Is the Iambic Therapeutics Market Cap?
As of today, Iambic Therapeutics market cap is 896,35M USD.
What Is Iambic Therapeutics's Earnings Per Share (TTM)?
The Iambic Therapeutics EPS (TTM) is -4,27.
How Many Times Has Iambic Therapeutics Stock Split?
Iambic Therapeutics has split 0 times.
How Many Employees Does Iambic Therapeutics Have?
Iambic Therapeutics has 171 employees.
What is the current trading status of Iambic Therapeutics (IAM)?
As of Oct 16, 2026, Iambic Therapeutics (IAM) is trading at a price of 24,77 USD, with a previous close of 18,91 USD. The stock has fluctuated within a day range of 19,31 USD to 24,87 USD, while its 52-week range spans from 16,15 USD to 24,87 USD.
What Is the IAM Premarket Price?
IAM's last pre-market stock price is 19,36 USD. The pre-market share volume is 51 230,00, and the stock has decreased by 0,45, or 2,38%.
What Is the IAM After Hours Price?
IAM's last after hours stock price is 18,93 USD, the stock has decreased by 0,02, or 0,11%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.